 |
Previous Article | Next Article 
The Journal of Neuroscience, March 15, 2002, 22(6):2225-2236
Versican Is Upregulated in CNS Injury and Is a Product of
Oligodendrocyte Lineage Cells
Richard A.
Asher1, 2,
Daniel A.
Morgenstern1, 2,
Morven C.
Shearer1, 2,
Kathryn H.
Adcock1, 2,
Penka
Pesheva3, and
James W.
Fawcett1, 2
1 Physiological Laboratory, University of Cambridge,
Downing Site, Cambridge CB2 3EG, United Kingdom,
2 Cambridge Centre for Brain Repair, Forvie Site,
Cambridge, CB2 2PY United Kingdom, and 3 Neuro- and Tumor
Cell Biology Group, Department of Nuclear Medicine, University of Bonn,
53105 Bonn, Germany
Chondroitin sulfate proteoglycan (CS-PG) expression is increased in
response to CNS injury and limits the capacity for axonal regeneration.
Previously we have shown that neurocan is one of the CS-PGs that is
upregulated (Asher et al., 2000). Here we show that another member of
the aggrecan family, versican, is also upregulated in response to CNS
injury. Labeling of frozen sections 7 d after a unilateral knife
lesion to the cerebral cortex revealed a clear increase in versican
immunoreactivity around the lesion. Western blot analysis of extracts
prepared from injured and uninjured tissue also revealed considerably
more versican in the injured tissue extract. In vitro
studies revealed versican to be a product of oligodendrocyte lineage
cells (OLCs). Labeling was seen between the late A2B5-positive stage
and the O1-positive pre-oligodendrocyte stage. Neither immature,
bipolar A2B5-positive cells, nor differentiated, myelin-forming
oligodendrocytes were labeled. The amount of versican in conditioned
medium increased as these cells differentiated. Versican and tenascin-R
colocalized in OLCs, and coimmunoprecipitation indicated that the two
exist as a complex in oligodendrocyte-conditioned medium. Treatment of
pre-oligodendrocytes with hyaluronidase led to the release of versican,
indicating that its retention at the cell surface is dependent on
hyaluronate (HA). In rat brain, approximately half of the versican is
bound to hyaluronate. We also provide evidence of a role for CS-PGs in
the axon growth-inhibitory properties of oligodendrocytes. Because
large numbers of OLCs are recruited to CNS lesions, these results
suggest that OLC-derived versican contributes to the inhospitable
environment of the injured CNS.
Key words:
chondroitin sulfate; extracellular matrix; glial scar; hyaluronate; proteoglycan; regeneration; tenascin-R
Copyright © 2002 Society for Neuroscience 0270-6474/02/2262225-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
H.T. Ghashghaei, J. M. Weimer, R. S. Schmid, Y. Yokota, K. D. McCarthy, B. Popko, and E.S. Anton
Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex
Genes & Dev.,
December 15, 2007;
21(24):
3258 - 3271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Barritt, M. Davies, F. Marchand, R. Hartley, J. Grist, P. Yip, S. B. McMahon, and E. J. Bradbury
Chondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord Injury.
J. Neurosci.,
October 18, 2006;
26(42):
10856 - 10867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Zacharias and U. Rauch
Competition and cooperation between tenascin-R, lecticans and contactin 1 regulate neurite growth and morphology.
J. Cell Sci.,
August 15, 2006;
119(Pt 16):
3456 - 3466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Haddock, A K Cross, J Plumb, J Surr, D J Buttle, R A. Bunning, and M N Woodroofe
Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter
Multiple Sclerosis,
August 1, 2006;
12(4):
386 - 396.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Y. Xiang, H. Dong, Y. Wan, J. Li, A. Yee, B. B. Yang, and W.-Y. Lu
Versican G3 Domain Regulates Neurite Growth and Synaptic Transmission of Hippocampal Neurons by Activation of Epidermal Growth Factor Receptor
J. Biol. Chem.,
July 14, 2006;
281(28):
19358 - 19368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Deepa, D. Carulli, C. Galtrey, K. Rhodes, J. Fukuda, T. Mikami, K. Sugahara, and J. W. Fawcett
Composition of Perineuronal Net Extracellular Matrix in Rat Brain: A DIFFERENT DISACCHARIDE COMPOSITION FOR THE NET-ASSOCIATED PROTEOGLYCANS
J. Biol. Chem.,
June 30, 2006;
281(26):
17789 - 17800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamagata and J. R. Sanes
Versican in the Developing Brain: Lamina-Specific Expression in Interneuronal Subsets and Role in Presynaptic Maturation
J. Neurosci.,
September 14, 2005;
25(37):
8457 - 8467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wu, W. Sheng, L. Chen, H. Dong, V. Lee, F. Lu, C. S. Wong, W.-Y. Lu, and B. B. Yang
Versican V1 Isoform Induces Neuronal Differentiation and Promotes Neurite Outgrowth
Mol. Biol. Cell,
May 1, 2004;
15(5):
2093 - 2104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Properzi and J. W. Fawcett
Proteoglycans and Brain Repair
Physiology,
February 1, 2004;
19(1):
33 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Jones, D. Sajed, and M. H. Tuszynski
Axonal Regeneration through Regions of Chondroitin Sulfate Proteoglycan Deposition after Spinal Cord Injury: A Balance of Permissiveness and Inhibition
J. Neurosci.,
October 15, 2003;
23(28):
9276 - 9288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Moreau-Fauvarque, A. Kumanogoh, E. Camand, C. Jaillard, G. Barbin, I. Boquet, C. Love, E. Y. Jones, H. Kikutani, C. Lubetzki, et al.
The Transmembrane Semaphorin Sema4D/CD100, an Inhibitor of Axonal Growth, Is Expressed on Oligodendrocytes and Upregulated after CNS Lesion
J. Neurosci.,
October 8, 2003;
23(27):
9229 - 9239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cattaruzza, M. Schiappacassi, A. Ljungberg-Rose, P. Spessotto, D. Perissinotto, M. Morgelin, M. T. Mucignat, A. Colombatti, and R. Perris
Distribution of PG-M/Versican Variants in Human Tissues and de Novo Expression of Isoform V3 upon Endothelial Cell Activation, Migration, and Neoangiogenesis in Vitro
J. Biol. Chem.,
November 27, 2002;
277(49):
47626 - 47635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Horner and F. H. Gage
Regeneration in the Adult and Aging Brain
Arch Neurol,
November 1, 2002;
59(11):
1717 - 1720.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Kwon, J. F. Borisoff, and W. Tetzlaff
Molecular Targets for Therapeutic Intervention after Spinal Cord Injury
Mol. Interv.,
July 1, 2002;
2(4):
244 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|